Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 53.37
-0.80 (-1.48%)
At close: Mar 6, 2026
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 2.9 billion as of March 6, 2026. Its market cap has decreased by -33.15% in one year.
Market Cap
2.90B
Enterprise Value
2.81B
Revenue
2.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
53.37
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 2.90B, a decrease of -60.81%. That is a compound annual growth rate of -32.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 2.94B | -22.61% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 11.90B |
| Sakar Healthcare | 11.75B |
| Jagsonpal Pharmaceuticals | 11.39B |
| Beta Drugs | 10.78B |
| Sigachi Industries | 7.40B |
| Bafna Pharmaceuticals | 2.58B |
| Nectar Lifesciences | 2.29B |
| Brooks Laboratories | 1.82B |